Koers Epsilon Healthcare Limited Other OTC
Aandelen
HDRPF
AU0000137598
Farmaceutische producten
Omzet 2021 | 5,5 mln. 3,62 mln. 3,35 mln. | Omzet 2022 | 7,11 mln. 4,68 mln. 4,33 mln. | Marktkapitalisatie | 7,51 mln. 4,94 mln. 4,57 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -9 mln. -5,92 mln. -5,48 mln. | Nettowinst (verlies) 2022 | -13 mln. -8,56 mln. -7,92 mln. | EV/omzet 2021 | 3,26 x |
Nettoschuld 2021 | 2,1 mln. 1,38 mln. 1,28 mln. | Nettoschuld 2022 | 2,34 mln. 1,54 mln. 1,42 mln. | EV/omzet 2022 | 1,38 x |
K/w-verhouding 2021 |
-1,48
x | K/w-verhouding 2022 |
-0,38
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 60,39% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Sanghera
CEO | Chief Executive Officer | - | 21/11 |
Lin Li
AUD | Comptroller/Controller/Auditor | - | - |
Marcelo Mora
SEC | Corporate Secretary | 60 | 23-12-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alan Beasley
CHM | Chairman | - | 29-08-16 |
Stuart Cameron
BRD | Director/Board Member | - | 27-10-22 |
Xiao Cui
CHM | Chairman | - | 28-10-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+46,03% | 754 mld. | |
+40,95% | 630 mld. | |
-5,91% | 352 mld. | |
+19,90% | 331 mld. | |
+9,64% | 298 mld. | |
+18,45% | 250 mld. | |
+11,88% | 217 mld. | |
-0,78% | 216 mld. | |
+5,92% | 164 mld. |